TCM
ALXO icon

Tekla Capital Management’s ALX Oncology ALXO Stock Holding History

Tekla Capital Management’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$497K Hold
66,211
– – 0.02% 143
2023
Q1 		$299K Hold
66,211
– – 0.01% 159
2022
Q4 		$746K Hold
66,211
– – 0.03% 137
2022
Q3 		$634K Hold
66,211
– – 0.03% 141
2022
Q2 		$536K Hold
66,211
– – 0.02% 150
2022
Q1 		$1.12M Hold
66,211
– – 0.04% 144
2021
Q4 		$1.42M Buy
66,211
+59,112
+833% +$2.55M 0.05% 137
2021
Q3 		$524K Buy
+7,099
New +$473K 0.02% 162

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Tekla Capital Management's ALXO Position: Q2 2023 in Review

Tekla Capital Management held its ALX Oncology (ALXO) position steady in Q2 2023 at 66,211 shares worth $497K. The position accounts for 0.02% of the portfolio, ranked #143.

Tekla Capital Management first reported a position in ALXO in Q3 2021 and has held it in 8 quarters since. The position peaked at $1.42M in Q4 2021. 75 funds tracked by Wall St. Rank hold ALXO as of Q2 2023.

  • Tekla Capital Management held 66,211 shares of ALX Oncology worth $497K as of Q2 2023.
  • Tekla Capital Management left its ALX Oncology share count unchanged in Q2 2023.
  • ALX Oncology made up 0.02% of Tekla Capital Management's portfolio in Q2 2023, its #143 holding.
  • Tekla Capital Management first reported a position in ALX Oncology in Q3 2021 and has held it in 8 quarters since.
  • Tekla Capital Management's ALX Oncology position peaked at $1.42M in Q4 2021.
  • 75 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2023.

Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.